USPTO serial 97085429
ANKET
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 17, 2023
- Examiner
- AURAND, MEGAN LEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ANKET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MARSEILLE, FR
MARSEILLE, FR
MARSEILLE, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Corey K. Cho
Corey K. Cho SALIWANCHIK LLOYD & EISENSCHENK, P.A.3107 SW WILLISTON RDGAINESVILLE, FL 32608UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical or biotechnological products for industry and science, namely, polypeptides and proteins; biological preparations, in particular antibodies in the nature of monoclonal antibodies, bispecific antibodies or multifunctional antibodies, antibody derivatives in the nature of antibody fragments, single-chain variable fragments, di-scFv, light and heavy chains of antibodies, binding proteins and peptides having a binding affinity to immune cells in the nature of T-cell engagers or NK-cell engagers, for laboratory and experimental purposes, in particular for conducting experimental tests other than for medical use; Biochemicals, namely, polypeptides for in vitro research use | ACTIVE | — |
| 005 | Pharmaceuticals, medical, biological or biochemical preparations, substances for the treatment of diseases, as well as preparations for medical treatments, in particular, antibodies and derivatives being monoclonal antibodies, bispecific antibodies, multispecific antibodies, antibody fragments, single-chain variable fragments, di-scFv or light and heavy chains of antibodies for medical purposes, bifunctional or multifunctional proteins being T-cell engagers or NK cell engagers for medical purposes with binding affinity to immune cells, in particular NK cells, and other reagents for the diagnosis, prevention, monitoring and treatment of diseases, in particular cancers, infectious diseases, inflammatory diseases, and other immune pathologies | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and development in scientific and medical matters, in particular in the field of immunotherapy; scientific and technological services, namely, scientific research and development related to diagnostic products; pharmaceutical and biotechnological scientific laboratory services; laboratory research, analysis, evaluation, development and clinical trial of therapeutic compositions and treatments in the field of oncology; all of the above services concerning the use of antibodies, antibody derivatives, proteins, or other agents for activating or modulating natural and adaptive immunity | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by INNATE PHARMA
- Other trademarks owned by INNATE PHARMA
- Other trademarks owned by INNATE PHARMA
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ANKET
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 17, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 17, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 1, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 1, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 12, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 27, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 24, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 23, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 23, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 8, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 28, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 7, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 25, 2021 | NWAP | NEW APPLICATION ENTERED | — |